Knowledge among patients with Hepatitis C initiating on direct-acting antiviral treatment in rural Rwanda
A prospective cohort study
Bibliographic Data
BACKGROUND: Curative direct-acting antiviral treatment (DAA) has made it plausible to implement hepatitis C elimination interventions. However, poor hepatitis C knowledge among patients could impede the effectiveness of screening and treatment programs. OBJECTIVE: We assessed knowledge on hepatitis C among rural Rwandans initiating DAA treatment for hepatitis C in a prospective cohort. METHODS: We administered 15 true-false statements before treatment initiation and during one follow-up visit occurring either 1 or 2 months after treatment initiation. We assessed the average number of correct responses per patient, the proportion of correct responses to individual statements, pre-treatment predictors of knowledge, and whether post-initiation knowledge was associated with time since treatment initiation, quality of care, or adherence. RESULTS: -value <0.001). Many patients still mistakenly believed that hepatitis C could be transmitted through kissing (66.5%), eating utensils (44.1%), handshakes (34.8%), and hugs (34.8%). Post-initiation knowledge is inversely associated with self-reported quality of care and unassociated with self-reported adherence. CONCLUSION: Although knowledge improved over time, key gaps persisted among patients. Accessible public education campaigns targeted to low-literacy populations emphasizing that hepatitis C can be asymptomatic, has severe consequences, and is curable could promote participation in mass screening campaigns and linkage to care. Visual tools could facilitate clinician-provided patient education
Antiviral treatment · Chronic hepatitis · Cohort · Cohort study · Environmental health · Family medicine · Hepatitis C · Prospective cohort study · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · Hepatitis Viruses Studies and Epidemiology · Medicine · Internal Medicine · Virology
Burden of liver diseases in the world
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B
The Redcap consortium
Assessing the level of knowledge and available sources of information about hepatitis C infection among HCV-infected Egyptians
Patient and healthcare provider experiences of hepatitis C treatment with direct-acting antivirals in Rwanda
Awareness, knowledge and self-reported test rates regarding Hepatitis B in Turkish-Dutch
Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV
| Highly cited | No |
|---|